Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands

Emerg Infect Dis. 2020 Nov;26(11):2761-2763. doi: 10.3201/eid2611.202736. Epub 2020 Jul 29.

Abstract

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Keywords: 2019 novel coronavirus disease; COVID-19; Denmark; Faroe Islands; SARS-CoV-2; antibodies; coronavirus disease; respiratory diseases; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood*
  • Betacoronavirus / immunology*
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / statistics & numerical data*
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Denmark / epidemiology
  • Female
  • Humans
  • Male
  • Pandemics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / epidemiology*
  • SARS-CoV-2
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Antibodies, Viral